Clinical trial
Tryptophan MRI in People With Schizophrenia and Healthy Controls
NCT02067975
Study timeline
Study start (actual)2014-08-14Date precision: day
Registry last updated2024-07-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
TryptophanDRUG · verified · RxNorm: tryptophan
PlaceboDRUG
Sponsors & collaborators
University of Maryland, Baltimorelead sponsor
Tanabe Pharma Corporationcollaborator
National Institute of Mental Health (NIMH)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02067975 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.